New Alzheimer's drug seeks to slow or stop memory loss
NASHVILLE, Tenn. (WZTV) — A nationwide study is testing a new drug to help combat a disease that plagues five million Americans - Alzheimer's.
The study is testing "troriluzole," a new investigational drug that might help to slow or stop memory loss and thinking problems with those already diagnosed with Alzheimer's disease.
"Troriluzole is a drug that modulates glutamate, protecting against neuron loss," the Alzheimer’s Disease Cooperative Study said in a release. "Glutamate problems in the brain can lead to brain cell dysfunction and disease, including Alzheimer’s disease."
"T2 Protect AD" study is testing folks from ages 50 to 85. It's being held in more than 30 cities around the United States.
According to the ADCS, about five million Americans have been diagnosed with Alzheimer's disease right now, and the number of people diagnosed with AD is expected to triple by 2050.
"The drug being studied in the T2 Protect trial is a neuroprotectant that may be beneficial to people with Alzheimer’s disease by improving symptoms and/or slowing the progression of the disease," ADCS said.
ADCS says this study is different and is meant to help people who already have mild to moderate Alzheimer's - while most other studies seek prevention.
Troriluzole was approved by the FDA in 1995 to slow progression of ALS, or Amyotrophic Lateral Sclerosis.